PREVENTION OF SUDDEN CARDIAC DEATH AFTER MYOCARDIAL INFARCTION BY DEFIBRILLATOR IMPLANTATION

Prevention of sudden cardiac death: from analysis of existing data to a large-scale clinical trial

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847999.

Latest news

FIRST PATIENTS ENROLLED IN THE PROFID EHRA TRIAL
The PROFID trial aims to reassess the role of routine prophylactic ICD implantation in patients with reduced LVEF ≤ 35% after myocardial infarction under contemporary OMT and is designed to be as close to routine clinical care as possible. The start of the PROFID clinical trial is a huge milestone.

Project Information

Grant agreement ID: 847999

DOI: 10.3030/847999

Start date: 1st January 2020
End date: 31st December 2024

Funded under: SOCIETAL CHALLENGES – Health, demographic change and well-being

Overall budget: € 23,307,508.08

Coordinated by: Helios Health Institute GmbH


Newsletter

SIgn up for the profid newsletter